ArticleBMC public health2026
Individual and community-level factors affecting diabetes screening uptake among adults in 14 low- and middle-income countries: a multilevel mixed-effects analysis of recent demographic and health surveys.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes screening is vital for the early detection and management of the condition, aiming to improve prognosis and prevent disease progression and complications. However, evidence on population‑level uptake of diabetes screening and its determinants in low‑ and middle‑income countries (LMICs) remains limited. Therefore, this study assessed uptake of diabetes screening and the associated individual‑ and community‑level factors among adults in LMICs.
methodsWe analysed recent Demographic and Health Surveys from 14 LMICs across Africa, South-East Asia, and the Americas. Weighted prevalence estimates of individuals who have ever undergone diabetes screening were calculated for each included country, by participant characteristics. Multilevel logistic regression models were fitted for each country to examine individual- and community-level determinants of diabetes screening uptake. Community variances, intraclass correlation coefficients, and proportional change in variance were used to measure community-level variability in diabetes screening uptake. Deviance, Akaike information criterion, and Bayesian Information criterion were used to select the best-fitting model for each survey. Adjusted odds ratios were used to estimate the association between covariates and diabetes screening uptake.
resultsThe prevalence of diabetes screening uptake varied widely across countries, ranging from 5.9% in Timor-Leste to 39.8% in the Dominican Republic. In most countries, women had significantly higher screening uptake than men. Older age, higher educational attainment, marital status, health insurance coverage, media exposure, and prior blood pressure measurement were consistently associated with increased likelihood of diabetes screening uptake across multiple surveys. At the community level, higher community media exposure and, in some contexts, higher community educational attainment were associated with greater odds of screening uptake. Substantial between‑community heterogeneity was observed, with intraclass correlation coefficients ranging from 6.8% to 40%.
conclusionDiabetes screening uptake remains suboptimal across many LMICs, with pronounced disparities by sex, socioeconomic status, and community characteristics. Strengthening health system performance, expanding health insurance coverage, increasing community‑level awareness, and better integrating diabetes screening into routine primary care may improve early detection. Addressing both individual‑ and structural‑level determinants is essential to enhancing screening uptake, reducing the burden of undiagnosed diabetes, and advancing global targets to mitigate diabetes‑related complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.